A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis
Authors
Keywords
-
Journal
BIOMATERIALS
Volume 289, Issue -, Pages 121781
Publisher
Elsevier BV
Online
2022-09-08
DOI
10.1016/j.biomaterials.2022.121781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospects of Immunotherapy for Triple-Negative Breast Cancer
- (2022) Dan Qiu et al. Frontiers in Oncology
- The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment
- (2021) Asieh Emami Nejad et al. Cancer Cell International
- Hypoxia‐sensitive micelles based on amphiphilic chitosan derivatives for drug‐controlled release
- (2021) Zhiming Chen et al. POLYMERS FOR ADVANCED TECHNOLOGIES
- A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis
- (2021) Ji Hyeon Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
- (2021) Wang Yin et al. Scientific Reports
- Mitochondrial H2Sn-Mediated Anti-Inflammatory Theranostics
- (2021) Won Young Kim et al. Nano-Micro Letters
- ROS activated prodrug for ALDH overexpressed cancer stem cells
- (2021) Miae Won et al. CHEMICAL COMMUNICATIONS
- The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
- (2021) Lin He et al. Cancers
- CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
- (2020) Kyuho Han et al. NATURE
- Mitochondrial Relocation of a Common Synthetic Antibiotic: A Non-genotoxic Approach to Cancer Therapy
- (2020) Kyoung Sunwoo et al. Chem
- Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
- (2020) Yena Cho et al. Frontiers in Oncology
- Hypoxia-mediated cancer stem cell resistance and targeted therapy
- (2020) Xiaoyu Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Recent advances in drug delivery systems for targeting cancer stem cells
- (2020) Hongxia Duan et al. Acta Pharmaceutica Sinica B
- Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
- (2020) Xupeng Bai et al. CANCER LETTERS
- Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
- (2020) Xiaobin Zeng et al. PHARMACOLOGICAL RESEARCH
- Chemoresistance mechanisms of breast cancer and their countermeasures
- (2019) Xiwei Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
- (2018) Christopher J O'Conor et al. Biomarkers in Medicine
- Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics
- (2018) Min Hee Lee et al. CHEMICAL SOCIETY REVIEWS
- Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
- (2018) Eunhye Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
- (2018) Christiana Neophytou et al. Frontiers in Oncology
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age
- (2016) Julia C. Radosa et al. ANNALS OF SURGICAL ONCOLOGY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting
- (2016) Bing Lu et al. Frontiers in Pharmacology
- CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination
- (2015) Abhilash K. Ravindranath et al. Oncotarget
- Overcoming Multidrug Resistance in Cancer Stem Cells
- (2015) Karobi Moitra Biomed Research International
- In Vivo Imaging of Multidrug Resistance Using a Third Generation MDR1 Inhibitor
- (2014) Melissa M. Sprachman et al. BIOCONJUGATE CHEMISTRY
- Comparative In Vivo Evaluations of Curcumin and Its Analog Difluorinated Curcumin Against Cisplatin-Induced Nephrotoxicity
- (2014) Kazim Sahin et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
- (2013) Qi Yin et al. ADVANCED DRUG DELIVERY REVIEWS
- The pre-metastatic niche: finding common ground
- (2013) Jaclyn Sceneay et al. CANCER AND METASTASIS REVIEWS
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells
- (2010) Shailender Singh Kanwar et al. PHARMACEUTICAL RESEARCH
- Hypoxia-inducible factor-1α enhances the malignant phenotype of multicellular spheroid HeLa cells in vitro
- (2010) XUN TIAN et al. Oncology Letters
- Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
- (2009) Francesca Greco et al. ADVANCED DRUG DELIVERY REVIEWS
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started